Filing Details

Accession Number:
0001209191-12-054421
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-23 14:01:07
Reporting Period:
2012-11-20
Filing Date:
2012-11-23
Accepted Time:
2012-11-23 14:01:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1254419 Medassets Inc MDAS Services-Prepackaged Software (7372) 510391128
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1415811 A Rand Ballard 100 North Point Center East
Suite 200
Alpharetta GA 30022
Chief Customer Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-11-20 18,602 $9.68 245,632 No 4 M Direct
Common Stock Disposition 2012-11-20 13,850 $16.05 231,782 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2012-11-20 6,605 $0.00 6,605 $9.68
Common Stock Stock Options (Right to Buy) Disposition 2012-11-20 11,996 $0.00 11,996 $9.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-10-01 No 4 M Direct
0 2016-07-05 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $15.95 2018-03-25 15,082 15,082 Direct
Common Stock Stock-Settled Stock Appreciation Rights $14.74 2016-01-05 88,166 88,166 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2018-03-25 15,082 15,082 Direct
2016-01-05 88,166 88,166 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2012.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.63, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
  3. The reporting person was granted these options on October 1, 2006 and are fully vested.
  4. The reporting person was granted these options on July 5, 2006 and are fully vested.
  5. The reporting person was granted these options on March 25, 2008. The options vest equally (over the course of 60 months) on the first day of each month beginning on March 1, 2008, such that 100% of the options will be fully vested on February 1, 2013.
  6. The reporting person was granted these stock-settled stock appreciation rights (SSARs) on January 5, 2009. The SSARs vest 25% annually beginning on December 31, 2009 such that 100% of the SSARs will be fully vested on December 31, 2012.